{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-024082","form_type":"8-K","ticker":"KAPA","cik":"0001962011","company_name":"Kairos Pharma, LTD.","filed_at":"2026-05-18T12:31:29+00:00","discovered_at":"2026-05-18T12:35:00.473488+00:00","generated_at":"2026-05-18T12:36:42.958838+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Kairos Pharma issues investor presentation for LD Micro Invitational; no material new data disclosed","bullets":["Company issued investor presentation for presentation at LD Micro Invitational on May 18-19, 2026.","CEO John Yu will present update on clinical program and partnering activities.","No specific financial results, milestones, or clinical data endpoints provided in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-024082","json":"https://secwatch.observer/filing/0001493152-26-024082.json","markdown":"https://secwatch.observer/filing/0001493152-26-024082.md","text":"https://secwatch.observer/filing/0001493152-26-024082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1962011/000149315226024082/0001493152-26-024082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1962011/000149315226024082/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T12:36:42.958838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}